Cícero Armídio Gomes Dias

Cícero Armídio Gomes Dias

Auto-generated profile, based on publicly available information

Cícero Armídio Gomes Dias

Affiliations Departamento de Epidemiologia e Métodos Diagnósticos, Programa de Pós Graduação Ciências da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA, Porto Alegre, Rio Grande do Sul, Brazil, Departamento de Ciências Básicas da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA, Porto Alegre, Rio Grande do Sul, Brazil

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in Journal of Medical Microbiology
Verified
Journal Article
Open access
CDCícero A. Dias
Cícero A. Dias
LTLúcia Martins Teixeira
Lúcia Martins Teixeira
MCMaria da Glória Carvalho
Maria da Glória Carvalho
BBBernard W Beall
Bernard W Beall
Capsular serotype surveillance of clinical isolates of Streptococcus pneumoniae is essential for evaluation of the potential impact of introducing multivalent capsular serotype-based vaccines in Latin America. Here, a previously described sequential multiplex PCR method was revised for optimal targeting of prevalent serotypes in Latin America. The revised protocol successfully serotyped 139/147 pneumococci (94.6 %) from Brazilian children, demonstrating a labour-efficient, accurate method requiring only conventional PCR capability.

1 April 2005 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
ARApoena Ribeiro
Apoena Ribeiro
CDCícEro Dias
CícEro Dias
MSMaria CícEra Silva-Carvalho
Maria CícEra Silva-Carvalho
LBLaura Berquó
Laura Berquó
FFFabienne Antunes Ferreira
Fabienne Antunes Ferreira
AFAgnes Marie Sá Figueiredo
Agnes Marie Sá Figueiredo
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has recently emerged in the southwestern Pacific, North America, and Europe. These S. aureus isolates frequently shared some genetic characteristics, including the SCC mec type IV and lukS-lukF genes. In this paper we show that typical CA-MRSA isolates have spread to South America (Brazil).

12 June 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
VDVanusa G Dutra
Vanusa G Dutra
VAValéria Mn Alves
Valéria Mn Alves
AOAndré N Olendzki
André N Olendzki
CDCicero Ag Dias
Cicero Ag Dias
ABAlessandra Fa de Bastos
Alessandra Fa de Bastos
SFSérgio Eduardo L Fracalanzza
Sérgio Eduardo L Fracalanzza
Group B Streptococcus (GBS) remains a major cause of neonatal sepsis and is also associated with invasive and noninvasive infections in pregnant women and non-pregnant adults, elderly and patients with underlying medical conditions. Ten capsular serotypes have been recognized, and determination of their distribution within a specific population or geographical region is important as they are major targets for the development of vaccine strategies. We have evaluated the characteristics of GBS isolates recovered from individuals with infections or colonization by this microorganism, living in different geographic regions of Brazil.

1 November 2007 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
ARApoena Ribeiro
Apoena Ribeiro
ACAmada Zambrana Coronado
Amada Zambrana Coronado
MSMaria Cícera Silva-Carvalho
Maria Cícera Silva-Carvalho
BFBernadete Teixeira Ferreira-Carvalho
Bernadete Teixeira Ferreira-Carvalho
CDCícero Dias
Cícero Dias
AFAgnes Marie Sá Figueiredo
Agnes Marie Sá Figueiredo

30 October 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JCJuliana Caierão
Juliana Caierão
PHPaulina Hawkins
Paulina Hawkins
FSFernando Hayashi Sant'Anna
Fernando Hayashi Sant'Anna
GCGabriela Rosa da Cunha
Gabriela Rosa da Cunha
PDPedro Alves D'Azevedo
Pedro Alves D'Azevedo
CDCícero Dias
Cícero Dias
To reduce the burden of pneumococcal diseases, different formulations of pneumococcal conjugate vaccines (PCV) have been introduced in many countries. In Brazil, PCV10 has been available since 2010. We aimed to analyze the serotype and genetic composition of invasive pneumococci from Brazil in pre- and post- vaccination periods (2007–2012). Antibiotic susceptibility was determined and genotypes of macrolide and fluoroquinolone resistance were characterized. The genotypes of isolates of the most frequent serotypes were determined by multilocus sequence typing. The study included 325 isolates, which were primarily recovered from blood. The most common serotypes recovered were 14, 3, 4, 23F, 7F, 9V, 12F, 20, 19F, 8, 19A, and 5. Thirty-eight pneumococci (11.7%) were from children ≤5 years old. Considering the overall population, PCV10 and PCV13 serotype coverage was 50.1% and 64.9%, respectively. During the pre-vaccine period, isolates with serotypes belonging to the PVC10 represented 51.5% (100/194), whereas in the post vaccine they represented 48.0% (63/131). PCV13 serotypes represented 67.5% (131/194) and 59.2% (77/131) of total for pre- and post-vaccination periods, respectively. Seventy different sequence types [STs] were found, accounting for 9 clonal complexes [CCs] and 45 singletons. Eight STs (156, 180, 218, 8889, 53, 191, 770, and 4967) represented the majority (51.5%) of isolates. Fifty STs were associated with the pre-vaccination period (27 exclusive) and 43 (20 exclusive) with the post-vaccination period; 23 STs were identified in both periods. Some serotypes were particularly clonal (7F, 8, 12F, 20). Non-susceptibility to penicillin was associated with serotype 19A, CC320. Erythromycin resistance was heterogeneous when considering serotype and ST. A single serotype 23F (ST4967) isolate was resistant to levofloxacin. Continued surveillance is required to determine vaccine impact and to monitor changes in pneumococcal population biology post-PCV10 introduction in Brazil.

22 February 2019 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
MMM.P. Mott
M.P. Mott
JCJ. Caierão
J. Caierão
GCG.R. Cunha
G.R. Cunha
MMM.M. Del Maschi
M.M. Del Maschi
KPK. Pizzutti
K. Pizzutti
CDC.A.G. Dias
C.A.G. Dias
Use of pneumococcal conjugate vaccines has caused emergence of non-vaccine serotypes. No Brazilian data specifically about serotype 19A are available. We aimed to evaluate the frequency of occurrence, susceptibility profile and molecular epidemiology of serotype 19A before and after vaccine introduction in Brazil. Pneumococcal identification was performed by the conventional method. Strain serotype was determined by multiplex polymerase chain reaction (PCR) and/or Quellung reaction. Resistance was determined by Etest®and PCR was performed to determine the presence of macrolide resistance genes,ermB and/ormefA. Pneumococci were typed by Multilocus Sequence Typing. Thirty-eight serotype 19AStreptococcus pneumoniaewere recovered, mostly from invasive diseases. Prevalence of serotype 19A increased following vaccination (from 3.5% before vaccination to 8.1% after,p= 0.04196). Non-susceptibility increased to most antimicrobials after vaccine introduction and was associated with clonal complex (CC)320. MLST showed nine different STs, which were grouped in one main CC: CC320 (63.9%). During the post-vaccination era, the frequency of this serotype increased significantly from 1.2% in 2011 to 18.5% in 2014 (p= 0.00001), with a concomitant decrease in the genetic variability: ST320 consistently predominated after vaccine-introduction (61.1%). Overall, our results showed a post-PCV10 increase in the frequency of serotype 19A. This was accompanied by a selection of CC320 and antimicrobial resistance.